5 months ago
WST
AnalystsDerik De BruinDerik De Bruin's Stock Forecasts
AnalystsDerik De Bruin
Analyst Ranking
Top 10%
#450 out of 4867 analysts
Average Return
+8.91%
Win Rate
59%60 out of 101
Risk vs Reward
Poor
Good
Derik De Bruin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exact Sciences CorpEXAS | +122.87% | $51.63 | $115.07 | 2018-08-02 - 2019-08-02 | Strong Buy |
Hologic IncHOLX | +118.26% | $34.06 | $74.34 | 2020-04-02 - 2021-04-01 | Strong Buy |
Talis Biomedical CorpTLIS | +84.89% | $49.65 | $7.50 | 2022-01-07 - 2023-01-06 | Sell |
Iqvia Holdings IncIQV | +78.91% | $141.94 | $253.94 | 2020-07-07 - 2021-07-07 | Strong Buy |
Fortrea Holdings IncFTRE | +78.05% | $28.84 | $6.33 | 2024-05-14 - 2025-04-29 | Sell |
Derik De Bruin Analyst Color
Get additional color on Derik De Bruin's coverage of popular stocks
5 months ago
STVN
5 months ago
LH
7 months ago
TMO
9 months ago
LH
2 years ago
STVN
2 years ago
WST
3 years ago
A
Derik De Bruin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Myriad Genetics IncMYGN | 5 | Sell | $11.00 | +52.78% | Maintains | 2 months ago |
Exact Sciences CorpEXAS | 7 | Strong Buy | $65.00 | +45.12% | Maintains | 2 months ago |
Neogenomics IncNEO | 4 | Hold | $16.00 | +143.16% | Maintains | 2 months ago |
Waters CorpWAT | 8 | Hold | $410.00 | +20.30% | Maintains | 3 months ago |
Agilent Technologies IncA | 21 | Hold | $156.00 | +45.17% | Maintains | 3 months ago |
Revvity IncRVTY | 5 | Strong Buy | $138.00 | +45.78% | Upgrades | 5 months ago |
Thermo Fisher Scientific IncTMO | 14 | Strong Buy | $660.00 | +54.38% | Maintains | 5 months ago |
Iqvia Holdings IncIQV | 2 | Strong Buy | $235.00 | +53.14% | Maintains | 5 months ago |
Charles River Laboratories International IncCRL | 5 | Hold | $210.00 | +79.04% | Maintains | 5 months ago |
West Pharmaceutical Services IncWST | 5 | Strong Buy | $355.00 | +66.31% | Maintains | 5 months ago |
Stevanato Group SpaSTVN | 3 | Strong Buy | $26.00 | +23.81% | Maintains | 5 months ago |
Labcorp Holdings IncLH | 4 | Strong Buy | $271.00 | +12.72% | Maintains | 5 months ago |
Quest Diagnostics IncDGX | 5 | Strong Buy | $182.00 | +1.96% | Maintains | 5 months ago |
Bruker CorpBRKR | 3 | Strong Buy | $80.00 | +100.80% | Maintains | 5 months ago |
Danaher CorpDHR | 4 | Strong Buy | $290.00 | +45.78% | Upgrades | 5 months ago |
Phibro Animal Health CorpPAHC | 2 | Sell | $15.00 | -20.55% | Maintains | 8 months ago |
Fortrea Holdings IncFTRE | 5 | Sell | $21.00 | +231.75% | Maintains | 9 months ago |
10x Genomics IncTXG | 6 | Hold | $25.00 | +198.33% | Maintains | 9 months ago |
Schrodinger IncSDGR | 1 | Hold | $32.00 | N/A | Maintains | a year ago |
Illumina IncILMN | 4 | Sell | $100.00 | N/A | Downgrades | a year ago |
Catalent IncCTLT | 7 | Sell | $46.00 | N/A | Maintains | 2 years ago |
Hologic IncHOLX | 6 | Hold | $86.00 | N/A | Maintains | 2 years ago |
EVO | 1 | Hold | $13.00 | N/A | Downgrades | 2 years ago |
Mettler Toledo International IncMTD | 4 | Hold | $1,525.00 | N/A | Maintains | 2 years ago |
Seer IncSEER | 1 | Sell | $6.50 | N/A | Downgrades | 2 years ago |
Icon PLCICLR | 1 | Strong Buy | $260.00 | N/A | Upgrades | 2 years ago |
Ginkgo Bioworks Holdings IncDNA | 3 | Sell | $120.00 | N/A | Downgrades | 3 years ago |
Talis Biomedical CorpTLIS | 3 | Sell | $22.50 | N/A | Maintains | 3 years ago |
Zymergen IncZY | 1 | Sell | $7.00 | N/A | Downgrades | 4 years ago |
Lucira Health IncLHDXQ | 1 | Sell | $9.00 | N/A | Downgrades | 4 years ago |
Qiagen NvQGEN | 4 | Strong Buy | $60.77 | N/A | Upgrades | 5 years ago |
Idexx Laboratories IncIDXX | 2 | Strong Buy | $235.00 | N/A | Maintains | 6 years ago |
Zoetis IncZTS | 1 | Strong Buy | $100.00 | N/A | Maintains | 7 years ago |
Abaxis IncABAX | 3 | Sell | $48.00 | N/A | Maintains | 7 years ago |
Pra Health Sciences IncPRAH | 1 | Strong Buy | $89.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.